Latest News & Features
Europe
The UK has been urged to back a proposed IP waiver related to COVID-19 treatments before the World Trade Organisation by business leaders, academics, economists and trade unions. 11 March 2021
Americas
AstraZeneca has won a three-year legal battle against UK generics manufacturer Mylan Pharmaceuticals over its asthma inhaler patents. 9 March 2021
Biotechnology
The fallout from the landmark Regeneron v Kymab is still being weighed by the UK life sciences community. 9 March 2021
Big Pharma
The director general of the World Health Organization has called for a waiver on IP rights to ensure more equitable access to COVID-19 vaccines. 9 March 2021
Big Pharma
On June 24, 2020, a seven-year long legal battle between two biotech companies finally concluded in the UK. 8 March 2021
Big Pharma
UK innovation hub CPI has received a further £5 million investment from the UK government to support the development of new mRNA vaccines to protect against new variants of COVID-19. 4 March 2021
Big Pharma
GlaxoSmithKline has avoided paying $57 million in damages after a US supreme court reversed a ruling that the pharmaceutical company should not have stopped issuing royalties on a lupus drug. 4 March 2021
article
Join LSPN Connect for an in-depth two-part look at the Regeneron v Kymab case. On Thursday, March 4, we will be joined by some of the participants of the latest proceedings before the UK Supreme Court. 4 March 2021
Medtech
Thom Tillis, ranking member of the senate IP subcommittee, has urged US president Joe Biden to oppose ‘harmful’ proposals to waive rights related to COVID-19 vaccines currently in discussions at the World Trade Organisation. 2 March 2021
Big Pharma
Los Angeles company Puma Biotechnology and Beijing-based CANBridge Pharmaceuticals have cancelled a 2018 licensing deal which gave the latter exclusive rights to a breast cancer drug in China. 2 March 2021